Compass Therapeutics, Inc. CMPX
Nov 10, 2026, 1:46 PM EST
- YTD
- -84.34%
- 1 year
- -80.35%
CMPX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-49,168,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -49,168,000 | -4,269,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -44,899,000 | -4,251,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -40,648,000 | -6,487,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -34,161,000 | -13,043,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -21,118,000 | Not available | Not available |
| FY 2020 | 2020-12-31 | Not available | Not available | Not available |
| FY 2019 | 2019-12-31 | -32,207,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:24:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.